Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: dkgross who wrote (41709)	4/6/2000 10:24:00 AM
From: SSP	Read Replies (1) \| Respond to of 150070

SHPH - Shaman Announces New Product Development SOUTH SAN FRANCISCO, Calif., Apr 6, 2000 (BW HealthWire) -- Shaman Pharmaceuticals, Inc. (OTCBB:SHPH), announced today that two new products are being developed and are expected to launch by the end of the second quarter 2000. Shaman also announced a new business focus. Through a subsidiary, to be named Shaman.com, the company intends to focus its efforts on a new content, education and media company. Shaman will continue to develop proprietary dietary supplements and health products through its division, ShamanBotanicals.com. The first new product line will be snack bars based on 30 years of clinical research conducted by Dr. Gerald Reaven and developed to combat Syndrome X. The first snack bars will follow the dietary guidelines of the Syndrome X Diet Plan. Future bars added to the Syndrome X bar line will contain proprietary dietary supplement ingredients from Shaman's library of medicinal plants. The second new product will be a proprietary dietary supplement that targets a health concern community of approximately 50 million Americans. The subsidiary, Shaman.com, will provide information, education, and entertainment through community building initiatives over the channels of the Internet, cable, and television from the perspective of the knowledgeable and trusted voice of natural products.. The goal of this effort is to bring natural medicine usage and information to the mass market, and to differentially expand the market for high quality products through communication of this information. Shaman Pharmaceuticals, Inc., through its ShamanBotanicals.com division, is focused on the discovery, development and commercialization of proprietary botanical dietary supplements from tropical plants for unmet healthcare needs through community building initiatives on the Internet and other focused channels. This press release contains, among other things, certain statements of a forward-looking nature relating to Shaman's ability to advance its development and research programs. Such statements involve a number of risks and uncertainties including the Risk Factors listed in the Pharmaceuticals, Inc.'s Annual Report on Form 10K for the year ended December 31, 1999. These filings are available upon request at 650/952-7070. Also visit Shaman at shamanbotanicals.com. Distributed via COMTEX. Copyright (C) 2000 Business Wire. All rights reserved. -0- CONTACT: Shaman Pharmaceuticals Inc., South San Francisco Corporate Communications, 650/952-7070